Pages that link to "Q54610409"

The following pages link to Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis. (Q54610409):

Displaying 46 items.

• Grb7 SH2 domain structure and interactions with a cyclic peptide inhibitor of cancer cell migration and proliferation (Q27648499) (← links)
• Water-Refined Solution Structure of the Human Grb7-SH2 Domain in Complex with the erbB2 Receptor Peptide pY1139 (Q27681182) (← links)
• Targeting GRB7/ERK/FOXM1 signaling pathway impairs aggressiveness of ovarian cancer cells (Q28484496) (← links)
• Regulation of stress granule dynamics by Grb7 and FAK signalling pathway (Q28863685) (← links)
• Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of Akt-mediated gene repression (Q33528957) (← links)
• Potential of phage-displayed peptide library technology to identify functional targeting peptides (Q33530848) (← links)
• Growth factor receptor-bound protein-7 (Grb7) as a prognostic marker and therapeutic target in breast cancer (Q33676758) (← links)
• The hypofunctional effect of P335L single nucleotide polymorphism on SSTR5 function (Q34065842) (← links)
• EGF-induced Grb7 recruits and promotes Ras activity essential for the tumorigenicity of Sk-Br3 breast cancer cells (Q34121550) (← links)
• Novel nonphosphorylated peptides with conserved sequences selectively bind to Grb7 SH2 domain with affinity comparable to its phosphorylated ligand (Q34130780) (← links)
• Preparation and crystallization of the Grb7 SH2 domain in complex with the G7-18NATE nonphosphorylated cyclic inhibitor peptide (Q34387280) (← links)
• Progress towards the development of SH2 domain inhibitors (Q34581878) (← links)
• Transcriptomic analysis of pancreatic cancer cells in response to metformin and aspirin: an implication of synergy (Q35979251) (← links)
• Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression. (Q36093867) (← links)
• Grb7 gene amplification and protein expression by FISH and IHC in ovarian cancer (Q36261762) (← links)
• Relationship between Quantitative GRB7 RNA Expression and Recurrence after Adjuvant Anthracycline Chemotherapy in Triple-Negative Breast Cancer (Q36603829) (← links)
• Combination treatment with Grb7 peptide and Doxorubicin or Trastuzumab (Herceptin) results in cooperative cell growth inhibition in breast cancer cells (Q36609570) (← links)
• Dissecting GRB7-mediated signals for proliferation and migration in HER2 overexpressing breast tumor cells: GTP-ase rules (Q36758884) (← links)
• Unexpected involvement of staple leads to redesign of selective bicyclic peptide inhibitor of Grb7. (Q36964946) (← links)
• The intertwining of structure and function: proposed helix-swapping of the SH2 domain of Grb7, a regulatory protein implicated in cancer progression and inflammation (Q37135451) (← links)
• Tyrosine phosphorylation of growth factor receptor-bound protein-7 by focal adhesion kinase in the regulation of cell migration, proliferation, and tumorigenesis (Q37339045) (← links)
• Receptor protein-tyrosine phosphatase α regulates focal adhesion kinase phosphorylation and ErbB2 oncoprotein-mediated mammary epithelial cell motility (Q37415599) (← links)
• Biomarkers for predicting future metastasis of human gastrointestinal tumors. (Q38078237) (← links)
• Molecular Pathogenesis and Targeted Therapy of Pancreatic Cancer (Q38370174) (← links)
• Cationic PTD/CPP-mediated macromolecular delivery: charging into the cell (Q38494545) (← links)
• Expression of connective tissue growth factor in the livers of non-viral hepatocellular carcinoma patients with metabolic risk factors. (Q38806090) (← links)
• Context-dependent role of Grb7 in HER2 ve and triple-negative breast cancer cell lines (Q39030506) (← links)
• Visualization of stem cell features in human hepatocellular carcinoma reveals in vivo significance of tumor-host interaction and clinical course. (Q39187561) (← links)
• The discovery of phenylbenzamide derivatives as Grb7-based antitumor agents (Q39203618) (← links)
• Contrast-enhanced intraoperative ultrasonography for vascular imaging of hepatocellular carcinoma: clinical and biological significance (Q39245130) (← links)
• Identification of Pancreatic Cancer Stem Cells and Selective Toxicity of Chemotherapeutic Agents (Q39363359) (← links)
• Interaction of the non‐phosphorylated peptide G7‐18NATE with Grb7‐SH2 domain requires phosphate for enhanced affinity and specificity (Q39418443) (← links)
• GRB7 is required for triple-negative breast cancer cell invasion and survival (Q39456781) (← links)
• Kinesin 18A expression: clinical relevance to colorectal cancer progression. (Q39611073) (← links)
• Uptake of a cell permeable G7-18NATE contruct into cells and binding with the Grb-7-SH2 domain (Q39690631) (← links)
• Insight into the Selectivity of the G7-18NATE Inhibitor Peptide for the Grb7-SH2 Domain Target (Q42103874) (← links)
• Non-ATP-competitive kinase inhibitors - enhancing selectivity through new inhibition strategies (Q43878954) (← links)
• Design and testing of bicyclic inhibitors of Grb7--are two cycles better than one? (Q44853520) (← links)
• Methylation-associated silencing of miR-193a-3p promotes ovarian cancer aggressiveness by targeting GRB7 and MAPK/ERK pathways. (Q47094453) (← links)
• Shortened Penetratin Cell-Penetrating Peptide Is Insufficient for Cytosolic Delivery of a Grb7 Targeting Peptide (Q47117237) (← links)
• Grb7 protein RA domain oligomerization (Q48124298) (← links)
• A novel therapeutic combination sequentially targeting aurora B and Bcl-xL in hepatocellular carcinoma. (Q53664285) (← links)
• Precision medicine based on surgical oncology in the era of genome-scale analysis and genome editing technology. (Q55033899) (← links)
• Polymers in gene therapy technology (Q57920735) (← links)
• Grb7, a Critical Mediator of EGFR/ErbB Signaling, in Cancer Development and as a Potential Therapeutic Target. (Q64972691) (← links)
• Mucinous cystadenocarcinoma of the pancreas developing during hormone replacement therapy (Q79988524) (← links)